中文版本

ST凯利泰2025年年度报告披露公告详解

证券代码：300326
证券简称：ST凯利
公告编号：2026-020
公告日期：2026年4月17日

重点内容摘要

• 年度报告已发布： 上海凯利泰医疗科技股份有限公司（以下简称“公司”）于2026年4月16日召开第六届董事会第十五次会议，审议通过了2025年年度报告及其摘要。
• 报告披露平台： 2025年年度报告及其摘要已于2026年4月17日在中国证监会指定的创业板信息披露网站正式披露，投资者可查阅详细内容。
• 披露内容的真实性保证： 董事会全体成员承诺公告内容真实、准确、完整，无虚假记载、误导性陈述或重大遗漏。

对投资者及股东的重大意义

• 全面了解公司经营与财务状况： 年度报告包含了公司2025年度的经营成果、财务状况以及未来发展规划，是投资者和股东判断公司投资价值和发展前景的重要依据。
• 潜在的价格敏感信息： 本次披露并未在公告中直接透露具体财务数据或经营变化，但由于年度报告和摘要已于官方渠道披露，投资者应及时查阅相关内容。任何有关公司盈利能力、资产负债情况、未来计划等重大信息，都可能对公司股票价格产生影响。
• 特别提示： 作为ST（*特别处理*）公司，任何经营、财务或合规上的重大变化都将被市场高度关注，并有可能导致股价剧烈波动。建议所有投资者尽快查阅详细年度报告，关注公司是否有退市风险、扭亏为盈、重大项目进展等敏感信息。

完整公告内容回顾

公司于2026年4月16日召开了第六届董事会第十五次会议，审议并通过了《关于公司<2025年年度报告>及其摘要的议案》。公司2025年年度报告及摘要已于2026年4月17日通过中国证监会指定创业板信息披露网站正式公开。公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。公司提醒广大投资者注意查阅相关文件，以全面了解公司的经营成果、财务状况和未来发展规划。

结论

本次公告主要内容是关于2025年年度报告及摘要的正式披露。由于年度报告是判断公司未来发展的关键文件，建议投资者密切关注相关内容，及时获取公司最新经营和财务信息，谨慎做出投资决策。

免责声明

本文仅基于公司公告内容进行解读，不构成任何投资建议。投资者应结合自身实际情况，仔细研读公司正式披露的年度报告及相关文件，理性判断投资风险。

English Version

Detailed Interpretation of ST KAILITAI 2025 Annual Report Disclosure Announcement

Stock Code: 300326
Stock Abbreviation: ST KAILITAI
Announcement Number: 2026-020
Announcement Date: April 17, 2026

Key Highlights

• Annual Report Released: Shanghai KAILITAI Medical Technology Co., Ltd. (the “Company”) held its 15th meeting of the 6th Board of Directors on April 16, 2026, and approved the 2025 Annual Report and its summary.
• Disclosure Platform: The 2025 Annual Report and its summary were officially disclosed on April 17, 2026, via the designated ChiNext information disclosure website of the China Securities Regulatory Commission. Investors can access the full content there.
• Authenticity Guarantee: The Board of Directors and all its members guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or major omissions.

Significance for Investors and Shareholders

• Comprehensive Insight into Operations and Financials: The annual report includes the company’s operating results, financial status, and future development plans for 2025. It is a crucial basis for investors and shareholders to judge the company’s investment value and future prospects.
• Potentially Price-Sensitive Information: The announcement itself does not disclose specific financial figures or operational changes, but as the annual report and summary have been officially published, investors should consult the full documents promptly. Any details on profitability, assets, liabilities, or future plans could significantly impact the share price.
• Special Note: As an ST (“Special Treatment”) company, any major changes in operations, finances, or compliance will be closely watched by the market, potentially causing large share price movements. Investors are urged to review the full annual report for information on delisting risks, turnaround performance, key project developments, and other sensitive issues.

Full Announcement Recap

On April 16, 2026, the company held its 15th meeting of the 6th Board of Directors and approved the 2025 Annual Report and its summary. The report and summary were officially disclosed on April 17, 2026, via the designated ChiNext information disclosure website. The company and all board members guarantee the authenticity, accuracy, and completeness of the information, with no false records, misleading statements, or major omissions. Investors are reminded to consult the relevant documents to gain a comprehensive understanding of the company’s operating results, financial status, and future plans.

Conclusion

The main content of this announcement is the official release of the 2025 annual report and its summary. As the annual report is a key document for judging the company’s future prospects, investors are strongly advised to review it in detail and obtain the most up-to-date operational and financial information before making any investment decisions.

Disclaimer

This article is an interpretation based solely on the company’s official announcement and does not constitute any investment advice. Investors should carefully read the formally disclosed annual report and related documents, and exercise prudent judgment regarding investment risks.

View ST凯利 Historical chart here